HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
K Yoshimura Selected Research
K Yoshimura Research Topics
Disease
10
Neoplasms (Cancer)
01/2022 - 09/2000
4
Breast Neoplasms (Breast Cancer)
01/2020 - 01/2001
3
Pain (Aches)
02/2016 - 08/2004
3
Infections
09/2001 - 03/2000
2
Esophageal Squamous Cell Carcinoma
02/2016 - 11/2000
2
Renal Cell Carcinoma (Grawitz Tumor)
04/2013 - 09/2001
2
Uveitis
01/2008 - 11/2007
2
Prostatic Neoplasms (Prostate Cancer)
01/2007 - 01/2004
2
Granuloma
01/2005 - 05/2001
2
Hyperthermia
12/2004 - 08/2004
2
Fever (Fevers)
08/2004 - 01/2000
2
Lung Neoplasms (Lung Cancer)
08/2004 - 03/2003
2
Hyperpigmentation
04/2003 - 03/2000
2
Urolithiasis
09/2001 - 11/2000
2
Hemorrhage
06/2001 - 01/2000
1
Muscular Dystrophies (Muscular Dystrophy)
10/2017
1
Ulcer
02/2016
1
Heartburn (Pyrosis)
02/2016
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
02/2016
1
Gastroesophageal Reflux (GERD)
02/2016
1
Pulmonary Tuberculosis
01/2015
1
Pemphigus (Pemphigus Vulgaris)
09/2014
1
Wound Infection (Wound Infections)
01/2012
1
Pneumonia (Pneumonitis)
09/2011
1
Stomach Neoplasms (Stomach Cancer)
06/2011
1
Pathologic Complete Response
07/2010
1
Carcinoma (Carcinomatosis)
07/2010
1
Convulsions benign familial neonatal dominant form
10/2009
1
Hypoxia (Hypoxemia)
10/2009
1
Necrosis
10/2009
1
Lipoma (Lipomata)
10/2009
1
Asthma (Bronchial Asthma)
01/2009
1
Inflammation (Inflammations)
01/2008
1
Cystitis
01/2008
1
Cataract (Cataracts)
11/2007
1
Infarction (Infarctions)
10/2007
1
Hydrocephalus (Hydrocephaly)
10/2007
1
Lung Diseases (Lung Disease)
06/2007
1
Varicose Veins (Varicose Vein)
11/2005
Drug/Important Bio-Agent (IBA)
3
Immunoglobulin A (IgA)
IBA
01/2015 - 07/2000
3
Antigens
IBA
07/2001 - 03/2000
2
Autoantibodies
IBA
09/2014 - 07/2001
2
Messenger RNA (mRNA)
IBA
10/2009 - 11/2001
2
N,N-dimethylarginine (asymmetric dimethylarginine)
IBA
01/2008 - 11/2007
2
Matrix Metalloproteinases (MMPs)
IBA
11/2005 - 03/2001
2
Carrageenan
IBA
12/2004 - 08/2004
2
Cisplatin (Platino)
FDA Link
Generic
03/2003 - 11/2000
2
Interleukin-5 (Interleukin 5)
IBA
04/2002 - 05/2001
2
Tretinoin (Retinoic Acid)
FDA Link
Generic
11/2001 - 03/2001
2
Calcium Oxalate
IBA
09/2001 - 11/2000
2
Interleukin-6 (Interleukin 6)
IBA
05/2001 - 09/2000
2
Cytokines
IBA
05/2001 - 01/2000
2
hydroquinone (Esoterica)
FDA Link
03/2001 - 03/2000
1
Lipids
IBA
01/2020
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
10/2017
1
Proton Pump Inhibitors
IBA
02/2016
1
human ERBB2 protein
IBA
12/2014
1
Sulfhydryl Compounds (Thiols)
IBA
09/2014
1
envoplakin
IBA
09/2014
1
Pharmaceutical Preparations
IBA
09/2014
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
04/2013
1
Protein Subunit Vaccines
IBA
04/2013
1
Docetaxel (Taxotere)
FDA Link
09/2012
1
Dihydrotachysterol (AT 10)
IBA
09/2012
1
Virulence Factors (Pathogenicity Factors)
IBA
09/2011
1
Membrane Proteins (Integral Membrane Proteins)
IBA
09/2011
1
S-1 plus cisplatin
IBA
06/2011
1
Trastuzumab (Herceptin)
FDA Link
07/2010
1
Potassium
IBA
10/2009
1
Plasminogen Activators (Plasminogen Activator)
IBA
10/2009
1
Adiponectin
IBA
10/2009
1
Leptin
IBA
10/2009
1
Facilitative Glucose Transport Proteins (Glucose Transporter)
IBA
10/2009
1
PPAR gamma
IBA
10/2009
1
Lectins
IBA
10/2009
1
Solutions
IBA
01/2009
1
Detergents (Detergent)
IBA
01/2009
1
Ethanolamine (Colamine)
IBA
01/2009
1
Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
IBA
01/2009
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
01/2008
1
Biomarkers (Surrogate Marker)
IBA
01/2008
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2008
1
pigment epithelium-derived factor
IBA
11/2007
1
Enzymes
IBA
11/2007
1
Immunosorbents
IBA
11/2007
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
11/2005
1
Oxidoreductases (Dehydrogenase)
IBA
11/2005
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
11/2005
1
Simvastatin (Zocor)
FDA Link
Generic
11/2005
1
Pravastatin (Pravachol)
FDA Link
Generic
11/2005
Therapy/Procedure
5
Therapeutics
02/2016 - 09/2000
3
Drug Therapy (Chemotherapy)
01/2022 - 01/2000
3
Radiotherapy
01/2007 - 12/2000
2
Nephrectomy
06/2001 - 02/2001
1
Conservative Treatment
01/2012
1
Adjuvant Chemotherapy
06/2011
1
Gastrectomy
06/2011
1
Neoadjuvant Therapy
07/2010
1
Ventriculostomy
10/2007
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2007